Andrea Casadei-Gardini

Presentation(s):

• SO-14: Atezolizumab Plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: An international study

  Thursday, June 30, 2022
  15:58 – 16:06